GSK Acquires Syndivia's Prostate Cancer ADC GSK has acquired the rights to Syndivia's preclinical antibody drug conjugate (ADC) for prostate cancer treatment. Despite having its own…
Importance of Experienced Lawyers in Personal Injury Cases Experienced personal injury lawyers can significantly impact the outcome of a c…
TechCrunch Disrupt 2025 Livestream TechCrunch Disrupt 2025 is underway. For those unable to attend in person, a livestream of the Disrupt …
Weekly Injectable Treatment for Parkinson's Disease Parkinson's disease, the second most common neurodegenerative disorder after Alzheimer…
Transmission Electron Microscopy (TEM) in Nano TEM is a crucial tool for characterizing nanomaterials, providing detailed imaging of morph…
US Contractor Agrees to Deep-Water Pact with Shell Halliburton will provide umbilical-less tubing hanger installation via remote operation…
Hamilton Criticizes Mexico GP Penalty Lewis Hamilton expressed frustration over the 10-second penalty he received at the Mexico City GP fo…
Acorns Invests In Financial Wellness For Overlooked Audience The "Show Your Potential" campaign features real-life, relatable stories.…
Novartis Acquires Avidity Biosciences Novartis has entered a $12 billion definitive merger agreement to acquire Avidity Biosciences, enhan…
How Perforated Sheets Can Help Elevate Modern Architecture Perforated metal has become a defining feature in modern architecture, offering…
Skeleton Technologies to Invest in Poland Estonian company Skeleton Technologies, a producer of supercapacitors and energy storage systems…